OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Direct and indirect effects of fibroblast growth factor 23 on the heart
Toshiaki Nakano, Hiroshi Kishimoto, Masanori Tokumoto
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17

Showing 17 citing articles:

Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging
Gérald J. Prud’homme, Qinghua Wang
Cells (2024) Vol. 13, Iss. 17, pp. 1413-1413
Open Access | Times Cited: 10

Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact
Ida G. Lunde, Karoline Bjarnesdatter Rypdal, Sophie Van Linthout, et al.
Matrix Biology (2024) Vol. 134, pp. 1-22
Closed Access | Times Cited: 7

Klotho in age-related cardiovascular diseases: Insights into mitochondrial dysfunction and cell death
Zohreh Zavvari Oskuye, Keyvan Mehri, Jamal Khalilpour, et al.
IJC Heart & Vasculature (2025) Vol. 57, pp. 101629-101629
Closed Access

Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging
Gérald J. Prud’homme, Qinghua Wang
(2024)
Open Access | Times Cited: 3

Erythropoietin alleviates lung ischemia-reperfusion injury by activating the FGF23/FGFR4/ERK signaling pathway
Xiaosheng Jin, Weijing Jin, Guoping Li, et al.
PeerJ (2024) Vol. 12, pp. e17123-e17123
Open Access | Times Cited: 2

Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure
Valeria Cernaro, Elisa Longhitano, Vincenzo Calabrese, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 15, pp. 1737-1746
Closed Access | Times Cited: 6

Cardiac and Renal Fibrosis, the Silent Killer in the Cardiovascular Continuum: An Up-to-Date
Traian Chiuariu, Delia Lidia Şalaru, Carina Ureche, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 2, pp. 62-62
Open Access | Times Cited: 1

Fibroblast growth factor 23 and calcium‐phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes
Stephanie Vermeulen, Mirjam E. A. Scheffer‐Rath, Martine Besouw, et al.
Journal of Diabetes (2023) Vol. 16, Iss. 6
Open Access | Times Cited: 2

piRNAs and miRNAs Can Bind to mRNA of <i>KLOTHO</i> and <i>FGF23</i> Genes
Ivashchenko At, Kyrmyzy Akhmetova, Murat Zhanuzakov, et al.
(2023)
Open Access | Times Cited: 1

Klotho protein, fibroblast growth factor 23, and sclerostin in chronic heart failure: literature review
Amina M. Alieva, Е. В. Резник, Irina A. Kotikova, et al.
Cardiosomatics (2024) Vol. 15, Iss. 1, pp. 41-53
Open Access

Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path
Luxuan Guo, Yue Ji, Tianhao Sun, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 6, pp. 232-232
Open Access

Clinical significance of adanced glycation end products and inflammation products in the development of vascular calcification and cardiovascular complications in chronic kidney disease
Ф. У. Дзгоева, О. В. Ремизов, Z. R. Ikoeva, et al.
Nephrology (Saint-Petersburg) (2023) Vol. 27, Iss. 3, pp. 68-75
Closed Access

11

Actual problems of modern medicine (2023), Iss. 11
Open Access

Page 1

Scroll to top